Quantitative computed tomography is unreliable for measurement of bone mineral density in inadequately chelated adolescent patients with β-thalassemia major: A case-control study

Pediatric Blood and Cancer

Volumn 56, Issue 3, 2011, Pages 409-412

  Bansal, Deepak ^a   Venkateshwaran, S ^a   Khandelwal, N ^a   Marwaha, R K ^a  

^a POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

Bone densitometry; Chelation; DXA; Pediatric

Indexed keywords

DEFERIPRONE; FERRITIN;

ADOLESCENT; ADULT; ARTICLE; BONE DENSITY; CHILD; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DELAYED PUBERTY; FEMALE; FERRITIN BLOOD LEVEL; GROWTH RETARDATION; HUMAN; IRON CHELATION; IRON OVERLOAD; LUMBAR VERTEBRA; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUANTITATIVE ANALYSIS; RELIABILITY; RISK FACTOR; SCHOOL CHILD; SEXUAL MATURITY; THALASSEMIA MAJOR;

ADOLESCENT; ADULT; BETA-THALASSEMIA; BONE DENSITY; CASE-CONTROL STUDIES; CHILD; FEMALE; HUMANS; INDIA; IRON CHELATING AGENTS; MALE; PROGNOSIS; PROSPECTIVE STUDIES; PYRIDONES; TOMOGRAPHY, X-RAY COMPUTED; YOUNG ADULT;

EID: 78651086501     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.22912     Document Type: Article

References (26)

1. Jensen CE, Tuck SM, Agnew JE, et al. High prevalence of low bone mass in thalassaemia major. Br J Haematol 1998; 103: 911-915.
2. Vogiatzi MG, Macklin EA, Fung EB, et al. Bone disease in thalassemia: A frequent and still unresolved problem. J Bone Miner Res 2009; 24: 543-557.
3. Dresner Pollack R, Rachmilewitz E, Blumenfeld A, et al. Bone mineral metabolism in adults with beta-thalassaemia major and intermedia. Br J Haematol 2000; 111: 902-907.
4. Higgs DR, Thein SL, Woods WG. The molecular pathology of the thalassaemias. In: Weatherall DJ, Clegg B, editors. The thalassaemia syndromes, 4th edition. Oxford, England: Blackwell Science; 2001. pp. 133-191.
5. Voskaridou E, Kyrtsonis MC, Terpos E, et al. Bone resorption is increased in young adults with thalassaemia major. Br J Haematol 2001; 112: 36-41.
6. Leung TF, Hung EC, Lam CW, et al. Bone mineral density in children. Bone Marrow Transplant 2005; 36: 331-336.
7. Bielinski BK, Darbyshire P, Mathers L, et al. Bone density in the Asian thalassaemic population: A cross-sectional review. Acta Paediatr 2001; 90: 1262-1266.
8. Baim S, Leonard MB, Bianchi ML, et al. Official Positions of the International Society for Clinical Densitometry and executive summary of the 2007 ISCD Pediatric Position Development Conference. J Clin Densitom 2008; 11: 6-21.
9. Bogunovic L, Doyle SM, Vogiatzi MG. Measurement of bone density in the pediatric population. Curr Opin Pediatr 2009; 21: 77-82.
10. van Rijn RR, van der Sluis IM, Link TM, et al. Bone densitometry in children: A critical appraisal. Eur Radiol 2003; 13: 700-710.
11. Leonard MB. Assessment of bone health in children and adolescents with cancer: Promises and pitfalls of current techniques. Med Pediatr Oncol 2003; 41: 198-207.
12. Griffith JF, Genant HK. Bone mass and architecture determination: State of the art. Best Pract Res Clin Endocrinol Metab 2008; 22: 737-764.
13. Mylona M, Leotsinides M, Alexandrides T, et al. Comparison of DXA, QCT and trabecular structure in β-thalassaemia. Eur J Haematol 2005; 74: 430-437.
14. Akpek S, Canatan D, Araç M, et al. Evaluation of osteoporosis in thalassemia by quantitative computed tomography: Is it reliable? Pediatr Hematol Oncol 2001; 18: 111-116.
15. Mahachoklertwattana P, Chuansumrit A, Choubtum L, et al. Bone mineral density in children and young adults with beta-thalassemia trait. J Pediatr Endocrinol Metab 2002; 15: 1531-1535.
16. Filosa A, Di Maio S, Vocca S, et al. Longitudinal monitoring of bone mineral density in thalassemic patients. Genetic structure and osteoporosis. Acta Paediatr 1997; 86: 342-346.
17. Molyvda-Athanasopoulou E, Sioundas A, Karatzas N, et al. Bone mineral density of patients with thalassemia major: Four-year follow-up. Calcif Tissue Int 1999; 64: 481-484.
18. Italian Working Group on Endocrine Complications in Non-Endocrine Diseases. Multicentre study on prevalence of endocrine complications in thalassaemia major. Clin Endocrinol (Oxf) 1995; 42: 581-586.
19. Anapliotou ML, Kastanias IT, Psara P, et al. The contribution of hypogonadism to the development of osteoporosis in thalassaemia major: New therapeutic approaches. Clin Endocrinol (Oxf) 1995; 42: 279-287.
20. Angastiniotis M, Pavlides N, Aristidou K, et al. Bone pain in thalassaemia: Assessment of DEXA and MRI findings. J Pediatr Endocrinol Metab 1998; 11: 779-784.
21. Drakonaki EE, Maris TG, Papadakis A, et al. Bone marrow changes in beta-thalassemia major: Quantitative MR imaging findings and correlation with iron stores. Eur Radiol 2007; 17: 2079-2087.
22. McDonald RA, Mallory GK. Hemochromatosis and hemosiderosis: Study of 211 autopsied cases. Arch Intern Med 1960; 105: 686-700.
23. Ladis V, Raptou P, Rigatou E, et al. Study of bone density by pQCT analysis in healthy adults and patients with β-thalassemia major and intermedia. Pediatr Endocrinol Rev 2008; 6: 127-131.
24. Angelopoulos NG, Katounda E, Rombopoulos G, et al. Evaluation of bone mineral density of the lumbar spine in patients with beta-thalassemia major with dual-energy x-ray absorptiometry and quantitative computed tomography: A comparison study. J Pediatr Hematol Oncol 2006; 28: 73-78.
25. Ladis VA, Gandaifis N, Papadopoulos EC, et al. Bone density study at the distal radius, using pQCT analysis, in Greek thalassemic patients. Pediatr Endocrinol Rev 2004; 2: 307-309.
26. Kalef-Ezra J, Zibis A, Chaliassos N, et al. Body composition in homozygous beta-thalassemia. Ann N Y Acad Sci 2000; 904: 621-624.